Michael Weigand
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Antimicrobial Resistance in Staphylococcus 1
-
- Sepsis Diagnosis and Treatment 2
- Co-authors
- Martin Röcken (1 shared paper)Ralph Mocikat (1 shared paper)Christoph Brenner (1 shared paper)David J. Roser (1 shared paper)Peter Eichhorn (3 shared papers)Daniel Teupser (3 shared papers)Mathias Bruegel (3 shared papers)Lesca M. Holdt (2 shared papers)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Annals of Intensive Care (1 paper)Frontiers in Immunology (1 paper)EMBO Molecular Medicine (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- GermanySwitzerlandFinland
In The Last Decade
Michael Weigand
8 papers receiving 236 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 54
- Immunology 64
- Infectious Diseases 53
- Microbiology 16
- Spectroscopy 31
Countries citing papers authored by Michael Weigand
This map shows the geographic impact of Michael Weigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weigand more than expected).
Fields of papers citing papers by Michael Weigand
This network shows the impact of papers produced by Michael Weigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weigand. The network helps show where Michael Weigand may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Weigand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 95 | |
| 2 | 2021 | 88 | |
| 3 | 2022 | 22 | |
| 4 | 2010 | 17 | |
| 5 | 2000 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2022 | 2 |
About Michael Weigand
Michael Weigand is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Surgery and Pharmacology, having authored 8 papers that have together received 238 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Sepsis Diagnosis and Treatment (2 papers), Thyroid Disorders and Treatments (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Hemodynamic Monitoring and Therapy (1 paper), Electrolyte and hormonal disorders (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Cancer Research (54 citations), Immunology (64 citations), Infectious Diseases (53 citations), Microbiology (16 citations) and Spectroscopy (31 citations). Michael Weigand has collaborated with scholars based in Germany, Switzerland and Finland. Frequent co-authors include Martin Röcken, Ralph Mocikat, Christoph Brenner, David J. Roser, Peter Eichhorn, Daniel Teupser, Mathias Bruegel, Lesca M. Holdt, Philipp E. Geyer and Sophia Doll. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Annals of Intensive Care, Frontiers in Immunology, EMBO Molecular Medicine and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.